An evaluation of prademagene zamikeracel for the treatment of recessive dystrophic epidermolysis bullosa
{{output}}
Introduction: Prademagene zamikeracel is an autologous, genetically corrected epidermal graft therapy designed to address the underlying molecular defect in recessive dystrophic epidermolysis bullosa (RDEB). The product is manufa... ...